These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8755500)

  • 1. Use of engineered ribozymes to catalyze chimeric gene assembly.
    Mikheeva S; Jarrell KA
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7486-90. PubMed ID: 8755500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of an engineered ribozyme to produce a circular human exon.
    Mikheeva S; Hakim-Zargar M; Carlson D; Jarrell K
    Nucleic Acids Res; 1997 Dec; 25(24):5085-94. PubMed ID: 9396820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of highly specific cytotoxins by using trans-splicing ribozymes.
    Ayre BG; Köhler U; Goodman HM; Haseloff J
    Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3507-12. PubMed ID: 10097066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization and application of the group I ribozyme trans-splicing reaction.
    Einvik C; Fiskaa T; Lundblad EW; Johansen S
    Methods Mol Biol; 2004; 252():359-71. PubMed ID: 15017063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and Experimental Evolution of trans-Splicing Group I Intron Ribozymes.
    Müller UF
    Molecules; 2017 Jan; 22(1):. PubMed ID: 28045452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Group I intron ribozymes.
    Nielsen H
    Methods Mol Biol; 2012; 848():73-89. PubMed ID: 22315064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA reprogramming of alpha-mannosidase mRNA sequences in vitro by myxomycete group IC1 and IE ribozymes.
    Fiskaa T; Lundblad EW; Henriksen JR; Johansen SD; Einvik C
    FEBS J; 2006 Jun; 273(12):2789-800. PubMed ID: 16817905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of activities between hammerhead ribozymes and DNA enzymes targeted to L6 BCR-ABL chimeric (b2a2) mRNA.
    Warashina M; Kuwabara T; Taira K
    Nucleic Acids Symp Ser; 1997; (37):213-4. PubMed ID: 9586075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterodimerization of Group I Ribozymes Enabling Exon Recombination through Pairs of Cooperative trans-Splicing Reactions.
    Tanaka T; Hirata Y; Tominaga Y; Furuta H; Matsumura S; Ikawa Y
    Chembiochem; 2017 Aug; 18(16):1659-1667. PubMed ID: 28556398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of circular RNA in bacteria and yeast using RNA cyclase ribozymes derived from a group I intron of phage T4.
    Ford E; Ares M
    Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3117-21. PubMed ID: 7512723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of in vitro splicing of the upstream intron by modifying an intra-exon sequence which is deleted from the dystrophin gene in dystrophin Kobe.
    Takeshima Y; Nishio H; Sakamoto H; Nakamura H; Matsuo M
    J Clin Invest; 1995 Feb; 95(2):515-20. PubMed ID: 7860733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribozyme-mediated repair of defective mRNA by targeted, trans-splicing.
    Sullenger BA; Cech TR
    Nature; 1994 Oct; 371(6498):619-22. PubMed ID: 7935797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trans-splicing ribozymes for targeted gene delivery.
    Köhler U; Ayre BG; Goodman HM; Haseloff J
    J Mol Biol; 1999 Feb; 285(5):1935-50. PubMed ID: 9925776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of active ribozymes from an RNA pool of random sequences using an anchored substrate RNA.
    Ishizaka M; Ohshima Y; Tani T
    Biochem Biophys Res Commun; 1995 Sep; 214(2):403-9. PubMed ID: 7545903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic characterization of group II intron folding and splicing.
    Fedorova O
    Methods Mol Biol; 2012; 848():91-111. PubMed ID: 22315065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRS1, a chloroplast group II intron splicing factor, promotes intron folding through specific interactions with two intron domains.
    Ostersetzer O; Cooke AM; Watkins KP; Barkan A
    Plant Cell; 2005 Jan; 17(1):241-55. PubMed ID: 15598799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribozyme expression systems.
    Sano M; Taira K
    Methods Mol Biol; 2004; 252():195-207. PubMed ID: 15017050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A shortened form of the Tetrahymena thermophila group I intron can catalyze the complete splicing reaction in trans.
    Sargueil B; Tanner NK
    J Mol Biol; 1993 Oct; 233(4):629-43. PubMed ID: 8411170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Group I and group II introns.
    Saldanha R; Mohr G; Belfort M; Lambowitz AM
    FASEB J; 1993 Jan; 7(1):15-24. PubMed ID: 8422962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA as a drug target: recent patents on the catalytic activity of trans-splicing ribozymes derived from group I intron RNA.
    Johnson IM
    Recent Pat DNA Gene Seq; 2010 Jan; 4(1):17-28. PubMed ID: 20218956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.